Literature DB >> 24595601

Amelioration of uremic tumoral calcinosis with high-flux hemodialysis treatment.

Tingting Xie1, Yong Zhang, Xiangling Tang, Mengying Chen, Weiru Zhang.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24595601     DOI: 10.1007/s11255-014-0654-9

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  5 in total

1.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

2.  Diffuse uremic tumoral calcinosis in a patient on long-term hemodialysis.

Authors:  Nessrine Akasbi; Tarik Sqalli Houssaini; Samira Rabhi; Mariam Lahlou; Amal Boukhrissa; Latifa Tahiri; Chakib El Maaroufi; Rhizlane Berrady; Taoufik Harzy; Wafaa Bono
Journal:  J Clin Rheumatol       Date:  2011-08       Impact factor: 3.517

3.  Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.

Authors:  Paul E Stevens; Adeera Levin
Journal:  Ann Intern Med       Date:  2013-06-04       Impact factor: 25.391

4.  Clinical Significance of FGF-23 in Patients with CKD.

Authors:  Domenico Russo; Yuri Battaglia
Journal:  Int J Nephrol       Date:  2011-04-26

Review 5.  Phosphate and FGF-23.

Authors:  Harald Jüppner
Journal:  Kidney Int Suppl       Date:  2011-02-23       Impact factor: 10.545

  5 in total
  1 in total

1.  Metastatic calcinosis cutis in end-stage renal disease.

Authors:  Victoria A Jaeger; Megan G Newman; Curtis R Mirkes
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.